SecBot SecBot
8-K ·Filed Oct 29, 2026

WST

WEST PHARMACEUTICAL SERVICES INC
BULLISH
Impact 6/10
Horizonweeks Processed3d 15h ago SEC0000105770-26-000118
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance and strong HVP Components growth (20.3% organic) signal sustained demand from biologics and GLP-1 customers. Monitor Q4 for continued margin expansion and any further updates on the West Vantage segment recovery from the cyber incident and customer loss.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

West Pharmaceutical reported Q3 2026 net sales of $874.5M (+8.7% reported, +11.9% organic) and adjusted-diluted EPS of $2.66 (+35.7% YoY), both exceeding consensus estimates of $826.5M and $2.20. The company raised its full-year 2026 net sales guidance to $3.41B-$3.42B and adjusted-diluted EPS guidance to $9.38-$9.48, driven by continued strength in High-Value Product Components (HVP Components up 20.3% organic) and margin expansion.

Key Financial Metrics

EPS (Adj.)
$2.66
est $2.20 · +20.9% · GAAP: $3.02
Revenue
$874.5M
est $826.5M · +5.8% · +8.7% YoY
Rating
strong beat
Guidance
$3.41B-$3.42B
raised
Free Cash Flow
$278.4M
Gross Margin
39.7%

Key Facts

  • Q3 2026 net sales of $874.5M, up 8.7% reported and 11.9% organic YoY
  • Adjusted-diluted EPS of $2.66, up 35.7% YoY, vs consensus of $2.20
  • GAAP diluted EPS of $3.02, up 57.3% YoY (includes $55.7M gain on SmartDose sale)
  • Full-year 2026 net sales guidance raised to $3.41B-$3.42B from $3.345B-$3.380B
  • Full-year 2026 adjusted-diluted EPS guidance raised to $9.38-$9.48 from $8.85-$9.05
  • HVP Components net sales of $466.7M, up 19.7% reported and 20.3% organic
  • Proprietary Products segment operating margin expanded 450 bps YoY to 31.6%
  • Company repurchased $231M of stock in Q3, $685M year-to-date
  • Dividend increased 18% to $0.26 per share from $0.22
  • West Vantage segment sales declined 7.3% reported and 6.6% organic due to planned CGM customer loss

Financial Impact

Q3 revenue beat consensus by $48.0M (5.8%), adjusted EPS beat by $0.46 (20.9%). Full-year guidance raised by $75M at midpoint for revenue and $0.48 at midpoint for adjusted EPS.

revenueepsoperating marginguidance

Segment Breakdown

SegmentRevenueGrowth
Proprietary Products$728.8M+12.6%
West Vantage$145.7M-7.3%

Risk Factors

  • West Vantage segment organic decline of 6.6% due to planned CGM customer loss
  • Generics market group organic decline of 4.5% in Proprietary Products
  • Year-to-date operating cash flow of $403.4M is down from $503.7M in the prior year period
  • Cybersecurity incident in May 2026 may have lingering operational impacts

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000105770-26-000118
Document: wst-20261029.htm0000105770-26-000118
Document: a3q26earningsdeck-final.htm0000105770-26-000118
Document: 0000105770-26-000118-index-headers.html0000105770-26-000118
Document: 0000105770-26-000118-index.html0000105770-26-000118
Document: 0000105770-26-000118.txt0000105770-26-000118
8-K Data (Synthetic)0000105770-26-000118
16 reports for WST
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 3 of 4 best @ T+60▲ +16.33%Apr 23, 2026
Filters
Rows
Reports for WST, sortable and filterable
TypeNow
Oct 29, 2026
3d ago
8-K
BULLISH ★ 6/10
No priceawaiting T+60awaiting T+60No price
Oct 29, 2026
3d ago
Press Release
BULLISH ★ 6/10
$416.67awaiting T+60awaiting T+60$412.62 (−0.97%)
Oct 26, 2026
6d ago
8-K
NEUTRAL ★ 4/10
$398.29awaiting T+60awaiting T+60$412.62 (+3.60%)
Oct 26, 2026
6d ago
Institutional Cluster
NEUTRAL ★ 3/10
$394.73awaiting T+60awaiting T+60$412.62 (+4.53%)
Jul 23, 2026
14w ago
8-K
BULLISH ★ 7/10
No priceawaiting T+60awaiting T+60No price
Jul 23, 2026
14w ago
Press Release
BULLISH ★ 7/10
$355.48 $383.02▲ +7.75%▲ +3.19%$412.62 (+16.07%)
Jul 7, 2026
16w ago
Press Release
NEUTRAL ★ 1/10
$356.08 $370.76▲ +4.12%▲ +2.13%$412.62 (+15.88%)
May 11, 2026
24w ago
8-K
BEARISH ★ 7/10
$311.82 $348.06▼ −11.62%▼ −7.51%$412.62 (−32.32%)
Apr 27, 2026
27w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $358.41▲ +19.10%▲ +14.59%$412.62 (+37.11%)
Apr 27, 2026
27w ago
Insider Cluster
NEUTRAL ★ 2/10
$300.93 $358.41▲ +19.10%▲ +14.59%$412.62 (+37.11%)
Showing 10 of 16

US Market Status

Market Closed · Opens Tue (11h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026